1
|
Diamond Model of Green Commitment and Low-Carbon Travel Motivation, Constraint, and Intention. INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH 2022; 19:ijerph19148454. [PMID: 35886303 PMCID: PMC9324020 DOI: 10.3390/ijerph19148454] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 06/05/2022] [Revised: 07/01/2022] [Accepted: 07/06/2022] [Indexed: 12/04/2022]
Abstract
Although consumers generally accept and care about environmental issues, consumers have not adjusted their behavior accordingly. Based on the diamond model theory, this study proposes and tests the direct impact of personal green commitments on low-carbon travel motivation and constraint, and the possibility of subsequent low-carbon travel intention. According to the results of 358 valid questionnaire surveys, this study shows that green commitments positively affect the low-carbon travel motivation and intention, while negatively affecting the low-carbon travel constraint. The low-carbon travel motivation has some mediating effects. The research results can be used as a reference by relevant managers of the tourism industry to make changes in the content of travel services that are more suitable for specific populations.
Collapse
|
2
|
Julio C, Benoist S, Allard MA, Navarro F, Pessaux P, Sa Cunha A, Brouquet A. Treatment strategies to resectable metachronous colorectal liver metastases after adjuvant oxaliplatin-based chemotherapy for primary colorectal cancer. J Surg Oncol 2022; 126:330-338. [PMID: 35397122 DOI: 10.1002/jso.26885] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/07/2022] [Accepted: 03/28/2022] [Indexed: 01/05/2023]
Abstract
BACKGROUND outcome of patients who develop resectable metachronous colorectal liver metastases (CLM) after adjuvant oxaliplatin-based chemotherapy for Stage III colorectal cancer (CRC) is not well defined and the value of preoperative chemotherapy is controversial. METHODS From 2006 to 2013, all patients undergoing liver resection for Class I metachronous CLM after adjuvant oxaliplatin-based chemotherapy for CRC, across 32 French academic centers, were included. RESULTS Sixty-two patients with an average of 2 ± 1 CLM were included. Thirty-two (52%) patients received preoperative chemotherapy. There was no significant difference in the characteristics of CLM between patients with or without preoperative chemotherapy. After a median follow-up of 29 months, 3-year overall and disease-free survival rates were 79.8% and 34.6%, respectively. The median disease-free survival was not different in patients with or without preoperative chemotherapy (17 vs. 35 months respectively, p = 0.112). In multivariate analysis, only CEA level > 200 ng/ml was associated with the risk of recurrence (p = 0.027; OR = 4.7, 95% CI = 1.2-18.7). CONCLUSION Liver resection provides a good outcome in patients with limited metachronous CLM after adjuvant oxaliplatin-based chemotherapy for CRC. The interest of preoperative chemotherapy is not obvious and should be tested in a prospective controlled study.
Collapse
Affiliation(s)
- Camille Julio
- The Department of Digestive and Oncologic Surgery, Bicêtre Hospital, APHP, Paris-Sud, University, Le Kremlin Bicêtre, France
| | - Stephane Benoist
- The Department of Digestive and Oncologic Surgery, Bicêtre Hospital, APHP, Paris-Sud, University, Le Kremlin Bicêtre, France.,Faculté de Médecine, Paris-Sud University, Le Kremlin Bicêtre, France
| | - Marc-Antoine Allard
- Faculté de Médecine, Paris-Sud University, Le Kremlin Bicêtre, France.,Department of Hepatobiliary and Pancreatic Surgery and Liver Transplantation, Paul Brousse Hospital, Villejuif, France
| | - Francis Navarro
- The Department of Digestive Surgery and Transplantation, Saint Eloi University Hospital, Montpellier, France
| | - Patrick Pessaux
- Department of General, Digestive, and Endocrine Surgery, Nouvel Hôpital Civil, Strasbourg, France
| | - Antonio Sa Cunha
- Faculté de Médecine, Paris-Sud University, Le Kremlin Bicêtre, France.,Department of Hepatobiliary and Pancreatic Surgery and Liver Transplantation, Paul Brousse Hospital, Villejuif, France
| | - Antoine Brouquet
- The Department of Digestive and Oncologic Surgery, Bicêtre Hospital, APHP, Paris-Sud, University, Le Kremlin Bicêtre, France.,Faculté de Médecine, Paris-Sud University, Le Kremlin Bicêtre, France
| | | |
Collapse
|
3
|
Ejaz A, Pawlik TM. We Need More Data: Choosing the Optimal Treatment Strategy for Patients with Resectable Metachronous Resectable Colorectal Liver Metastases. World J Surg 2021; 45:831-832. [PMID: 33386453 DOI: 10.1007/s00268-020-05894-4] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 11/27/2020] [Indexed: 11/24/2022]
Affiliation(s)
- Aslam Ejaz
- Department of Surgery, The Ohio State University Wexner Medical Center, 320 W. 10thAvenue, M-260 Starling Loving Hall, Columbus, OH, 43210, USA.
| | - Timothy M Pawlik
- Department of Surgery, The Ohio State University Wexner Medical Center, 320 W. 10thAvenue, M-260 Starling Loving Hall, Columbus, OH, 43210, USA
| |
Collapse
|